%0 Journal Article
%K Schistosomiasis 
%K arpraziquantel
%K Pre-school age children
%K Early economic evaluation
%K Economic model
%B The Lancet Regional Health - Africa
%D 2026
%G ENG
%I Elsevier BV
%P 1 - 14
%R 10.1016/j.lanafr.2026.100174
%T Cost-benefit analysis of arpraziquantel compared to standard of care for schistosomiasis among pre-school age children in Tanzania: an early health economic evaluation
%U https://www.thelancet.com/action/showPdf?pii=S3050-5011%2826%2900155-0
%8 10/2026
%9 Article